Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
ATTENTION GARDASIL REPS / MFG SITES
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3850650"]Anything's possible of course but this would mean that sales are only 25% of plan. Doesn't seem likely that Merck would wish to refrigerate all this just to toss it at expiry. </p><p>Manufacturing sites are expected to get clobbered when they are responsible for a stock-out but they also get hit if they manufacture foolishly to invventory. They put the brakes on producing to inventory well before they get to 4X demand. Cases where demand suddenly dries up will cause these types of numbers. Just a softening of demand ordinarily won't result in the numbers you state. More plausible is that the production capacity presently approved now has become capable of a peak production of 3-4 times actual demand. Something like 1.5 to 2 times average demand would be a good planned peak capacity for an injectable.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3850650"]Anything's possible of course but this would mean that sales are only 25% of plan. Doesn't seem likely that Merck would wish to refrigerate all this just to toss it at expiry. Manufacturing sites are expected to get clobbered when they are responsible for a stock-out but they also get hit if they manufacture foolishly to invventory. They put the brakes on producing to inventory well before they get to 4X demand. Cases where demand suddenly dries up will cause these types of numbers. Just a softening of demand ordinarily won't result in the numbers you state. More plausible is that the production capacity presently approved now has become capable of a peak production of 3-4 times actual demand. Something like 1.5 to 2 times average demand would be a good planned peak capacity for an injectable.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
ATTENTION GARDASIL REPS / MFG SITES
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Merck
>
ATTENTION GARDASIL REPS / MFG SITES
>